Newron Pharmaceuticals SpA (NWRN) Eur0.20

Sell:7.72 CHFBuy:8.25 CHF0.06 CHF (0.74%)

Prices delayed by at least 15 minutes
Sell:7.72 CHF
Buy:8.25 CHF
Change:0.06 CHF (0.74%)
Prices delayed by at least 15 minutes
Sell:7.72 CHF
Buy:8.25 CHF
Change:0.06 CHF (0.74%)
Prices delayed by at least 15 minutes

Director deals

Listed below are trades carried out by directors and other individuals which are required to be notified to the market.

Recent deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
27 June 2024
Stefan WeberCEO
Buy
Regular purchase transaction
2,500€8.76€21,900.0022,851
25 June 2024
Ulrich KostlinChairman of the Board
Buy
Regular purchase transaction
1,427€10.20€14,555.4050,249
25 June 2024
Ulrich KostlinChairman of the Board
Buy
Regular purchase transaction
1,0759.80 CHF10,535.00 CHF48,822
17 June 2024
Ulrich KostlinChairman of the Board
Buy
Regular purchase transaction
2,573€10.20€26,244.6047,747
17 June 2024
Ulrich KostlinChairman of the Board
Buy
Regular purchase transaction
2,9259.80 CHF28,665.00 CHF45,174
14 June 2024
Ulrich KostlinChairman of the Board
Buy
Regular purchase transaction
2,000€10.22€20,440.0042,249
16 May 2024
Luca BenattiDirector
Sell
Option/Award related
10,38210.47 CHF108,676.70 CHF0

End of results. Director deals are only available for the last 12 months.

5 most significant deals

DateName and position (if held)Deal typeNumber of
shares dealt
Price per
share
Value of
trade
Shares
remaining
16 May 2024
Luca BenattiDirector
Sell
Option/Award related
10,38210.47 CHF108,676.70 CHF0
17 June 2024
Ulrich KostlinChairman of the Board
Buy
Regular purchase transaction
2,9259.80 CHF28,665.00 CHF45,174
17 June 2024
Ulrich KostlinChairman of the Board
Buy
Regular purchase transaction
2,573€10.20€26,244.6047,747
27 June 2024
Stefan WeberCEO
Buy
Regular purchase transaction
2,500€8.76€21,900.0022,851
14 June 2024
Ulrich KostlinChairman of the Board
Buy
Regular purchase transaction
2,000€10.22€20,440.0042,249

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.